Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 73

1.

Subcomponent vaccine based on CTA1-DD adjuvant with incorporated UreB class II peptides stimulates protective Helicobacter pylori immunity.

Nedrud JG, Bagheri N, Schön K, Xin W, Bergroth H, Eliasson DG, Lycke NY.

PLoS One. 2013 Dec 31;8(12):e83321. doi: 10.1371/journal.pone.0083321. eCollection 2013.

2.

Vaccinating against Helicobacter pylori in the developing world.

Zawahir S, Czinn SJ, Nedrud JG, Blanchard TG.

Gut Microbes. 2013 Nov-Dec;4(6):568-76. doi: 10.4161/gmic.27093. Epub 2013 Nov 6. Review.

3.

Th1-mediated immunity against Helicobacter pylori can compensate for lack of Th17 cells and can protect mice in the absence of immunization.

Ding H, Nedrud JG, Blanchard TG, Zagorski BM, Li G, Shiu J, Xu J, Czinn SJ.

PLoS One. 2013 Jul 11;8(7):e69384. doi: 10.1371/journal.pone.0069384. Print 2013.

4.

Lack of genetic influence on the innate inflammatory response to helicobacter infection of the gastric mucosa.

Nedrud JG, Czinn SJ, Ding H, Zagorski BM, Redline RW, Twaddell W, Blanchard TG.

Front Immunol. 2012 Jul 4;3:181. doi: 10.3389/fimmu.2012.00181. eCollection 2012.

5.

Laboratory maintenance of Helicobacter species.

Blanchard TG, Nedrud JG.

Curr Protoc Microbiol. 2012 Feb;Chapter 8:Unit8B.1. doi: 10.1002/9780471729259.mc08b01s24.

PMID:
22307553
6.

Vaccine-induced immunity against Helicobacter pylori in the absence of IL-17A.

DeLyria ES, Nedrud JG, Ernst PB, Alam MS, Redline RW, Ding H, Czinn SJ, Xu J, Blanchard TG.

Helicobacter. 2011 Jun;16(3):169-78. doi: 10.1111/j.1523-5378.2011.00839.x.

7.

Partial protection against Helicobacter pylori in the absence of mast cells in mice.

Ding H, Nedrud JG, Wershil B, Redline RW, Blanchard TG, Czinn SJ.

Infect Immun. 2009 Dec;77(12):5543-50. doi: 10.1128/IAI.00532-09. Epub 2009 Oct 12.

8.

Laboratory maintenance of helicobacter species.

Blanchard TG, Nedrud JG.

Curr Protoc Microbiol. 2006 Jan;Chapter 8:Unit8B.1. doi: 10.1002/9780471729259.mc08b01s00.

9.

T cell cytokine polarity as a determinant of immunoglobulin A (IgA) glycosylation and the severity of experimental IgA nephropathy.

Chintalacharuvu SR, Yamashita M, Bagheri N, Blanchard TG, Nedrud JG, Lamm ME, Tomino Y, Emancipator SN.

Clin Exp Immunol. 2008 Sep;153(3):456-62. doi: 10.1111/j.1365-2249.2008.03703.x. Epub 2008 Jul 11.

10.

Helicobacter animal models.

Nedrud JG, Blanchard TG.

Curr Protoc Immunol. 2001 May;Chapter 19:Unit 19.8. doi: 10.1002/0471142735.im1908s36.

PMID:
18432759
11.

Analysis of innate immune responses in a model of IgA nephropathy induced by Sendai virus.

Yamashita M, Chintalacharuvu SR, Kobayashi N, Nedrud JG, Lamm ME, Tomino Y, Emancipator SN.

Contrib Nephrol. 2007;157:159-63. Review.

PMID:
17495456
12.

Helicobacter pylori vaccines: is DNA the answer?

Emancipator D, Nedrud JG, Czinn SJ.

Helicobacter. 2006 Dec;11(6):513-6. No abstract available.

PMID:
17083371
13.

The role of nasal tolerance in a model of IgA nephropathy induced in mice by Sendai virus.

Amore A, Coppo R, Nedrud JG, Sigmund N, Lamm ME, Emancipator SN.

Clin Immunol. 2004 Oct;113(1):101-8.

PMID:
15380535
14.

Differential effects of Sendai virus infection on mediator synthesis by mesangial cells from two mouse strains.

Kobayashi N, Bagheri N, Nedrud JG, Strieter RM, Tomino Y, Lamm ME, Emancipator SN.

Kidney Int. 2003 Nov;64(5):1675-84.

15.

Vaccine-induced protection against Helicobacter pylori in mice lacking both antibodies and interleukin-4.

Garhart CA, Nedrud JG, Heinzel FP, Sigmund NE, Czinn SJ.

Infect Immun. 2003 Jun;71(6):3628-33.

16.

Protective efficacy of anti-Helicobacter pylori immunity following systemic immunization of neonatal mice.

Eisenberg JC, Czinn SJ, Garhart CA, Redline RW, Bartholomae WC, Gottwein JM, Nedrud JG, Emancipator SE, Boehm BB, Lehmann PV, Blanchard TG.

Infect Immun. 2003 Apr;71(4):1820-7.

18.

Helicobacter pylori inflammation and immunity.

Nedrud JG, Blanchard SS, Czinn SJ.

Helicobacter. 2002;7 Suppl 1:24-9. Review.

PMID:
12197906
19.
20.

T cell cytokines determine the severity of experimental IgA nephropathy by regulating IgA glycosylation.

Chintalacharuvu SR, Nagy NU, Sigmund N, Nedrud JG, Amm ME, Emancipator SN.

Clin Exp Immunol. 2001 Nov;126(2):326-33.

21.

Protective anti-Helicobacter immunity is induced with aluminum hydroxide or complete Freund's adjuvant by systemic immunization.

Gottwein JM, Blanchard TG, Targoni OS, Eisenberg JC, Zagorski BM, Redline RW, Nedrud JG, Tary-Lehmann M, Lehmann PV, Czinn SJ.

J Infect Dis. 2001 Aug 1;184(3):308-14. Epub 2001 Jul 10.

PMID:
11443556
22.

Helicobacter pylori vaccines: lessons from small animal models.

Nedrud JG.

Scand J Immunol. 2001 May;53(5):429-36. Review. No abstract available.

23.

IgA immunodeficiency leads to inadequate Th cell priming and increased susceptibility to influenza virus infection.

Arulanandam BP, Raeder RH, Nedrud JG, Bucher DJ, Le J, Metzger DW.

J Immunol. 2001 Jan 1;166(1):226-31.

24.

Local and systemic antibody responses in humans with Helicobacter pylori infection.

Blanchard TG, Nedrud JG, Czinn SJ.

Can J Gastroenterol. 1999 Sep;13(7):591-4.

PMID:
10519957
25.

Host, heredity and helicobacter.

Nedrud JG, Czinn SJ.

Gut. 1999 Sep;45(3):323-4. No abstract available.

26.

Phagocytic antigen processing and effects of microbial products on antigen processing and T-cell responses.

Ramachandra L, Chu RS, Askew D, Noss EH, Canaday DH, Potter NS, Johnsen A, Krieg AM, Nedrud JG, Boom WH, Harding CV.

Immunol Rev. 1999 Apr;168:217-39. Review.

PMID:
10399077
27.

Animal models for gastric Helicobacter immunology and vaccine studies.

Nedrud JG.

FEMS Immunol Med Microbiol. 1999 Jun;24(2):243-50. Review.

28.

Replication and budding of simian immunodeficiency virus in polarized epithelial cells.

Huang YT, Miller CJ, Wong V, Fujioka H, Nedrud JG, Lamm ME.

Virology. 1999 Apr 25;257(1):24-34.

29.

Working towards a Helicobacter pylori vaccine.

Czinn SJ, Nedrud JG.

Gastroenterology. 1999 Apr;116(4):990-3. No abstract available.

PMID:
10092323
30.

Host response and vaccine development to Helicobacter pylori infection.

Blanchard TG, Czinn SJ, Nedrud JG.

Curr Top Microbiol Immunol. 1999;241:181-213. Review.

PMID:
10087662
31.
32.
33.

Antibody-independent protective mucosal immunity to gastric helicobacter infection in mice.

Blanchard TG, Czinn SJ, Redline RW, Sigmund N, Harriman G, Nedrud JG.

Cell Immunol. 1999 Jan 10;191(1):74-80.

PMID:
9918689
34.
36.

Role of the host in Helicobacter disease.

Nedrud JG, Czinn SJ, Lee A.

Gastroenterology. 1997 Feb;112(2):670. No abstract available.

PMID:
9024326
37.

Immunopathology of Helicobacter pylori infection and disease.

Czinn SJ, Nedrud JG.

Springer Semin Immunopathol. 1997;18(4):495-513. Review. No abstract available.

PMID:
9144867
38.

Therapeutic immunization against Helicobacter mustelae in naturally infected ferrets.

Cuenca R, Blanchard TG, Czinn SJ, Nedrud JG, Monath TP, Lee CK, Redline RW.

Gastroenterology. 1996 Jun;110(6):1770-5.

PMID:
8964402
39.

IL-6-deficient mice exhibit normal mucosal IgA responses to local immunizations and Helicobacter felis infection.

Bromander AK, Ekman L, Kopf M, Nedrud JG, Lycke NY.

J Immunol. 1996 Jun 1;156(11):4290-7.

PMID:
8666800
41.

Vaccine strategies for prevention of Helicobacter pylori infection.

Sellman S, Blanchard TG, Nedrud JG, Czinn SJ.

Eur J Gastroenterol Hepatol. 1995 Aug;7 Suppl 1:S1-6.

PMID:
8574728
42.

Urease-specific monoclonal antibodies prevent Helicobacter felis infection in mice.

Blanchard TG, Czinn SJ, Maurer R, Thomas WD, Soman G, Nedrud JG.

Infect Immun. 1995 Apr;63(4):1394-9.

43.

IgA and mucosal defense.

Lamm ME, Nedrud JG, Kaetzel CS, Mazanec MB.

APMIS. 1995 Apr;103(4):241-6. Review.

PMID:
7612253
44.

Helicobacter-associated gastritis in SCID mice.

Blanchard TG, Czinn SJ, Nedrud JG, Redline RW.

Infect Immun. 1995 Mar;63(3):1113-5.

45.

Intracellular neutralization of Sendai and influenza viruses by IgA monoclonal antibodies.

Mazanec MB, Kaetzel CS, Lamm ME, Fletcher D, Peterra J, Nedrud JG.

Adv Exp Med Biol. 1995;371A:651-4. No abstract available.

PMID:
8526010
46.

New functions for mucosal IgA.

Lamm ME, Mazaneca MB, Nedrud JG, Kaetzel CS.

Adv Exp Med Biol. 1995;371A:647-50. No abstract available.

PMID:
8526009
47.

Oral immunization induces humoral and cell-mediated immunity and protects germ-free mice against infection from Helicobacter felis.

Czinn SJ, Cai A, Sellman SP, Nedrud JG.

Adv Exp Med Biol. 1995;371B:1645-8. No abstract available.

PMID:
7502874
48.

A three-tiered view of the role of IgA in mucosal defense.

Mazanec MB, Nedrud JG, Kaetzel CS, Lamm ME.

Immunol Today. 1993 Sep;14(9):430-5. Review.

PMID:
8216720
49.
50.

Experimental IgA-IgG nephropathy induced by a viral respiratory pathogen. Dependence on antigen form and immune status.

Jessen RH, Emancipator SN, Jacobs GH, Nedrud JG.

Lab Invest. 1992 Sep;67(3):379-86.

PMID:
1328763

Supplemental Content

Loading ...
Support Center